Management of cryptococcosis: how are we doing?
- PMID: 17284156
- PMCID: PMC1808087
- DOI: 10.1371/journal.pmed.0040047
Management of cryptococcosis: how are we doing?
Abstract
Perfect discusses the implications of a national prospective study (the "CryptoA/D" study) of the factors influencing clinical presentation and outcome of patients with cryptococcosis.
Conflict of interest statement
Figures
Comment on
-
Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.PLoS Med. 2007 Feb;4(2):e21. doi: 10.1371/journal.pmed.0040021. PLoS Med. 2007. PMID: 17284154 Free PMC article.
References
-
- Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O, the French Cryptococcus Study Group Determinants of disease prevention and outcome during cryptococcosis. The Crypto A/D Study. PLoS Med. 2007;4:e21. doi: 10.1371/journal.pmed.0040021. - DOI - PMC - PubMed
-
- Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature. 2005;437:1360–1364. - PubMed
-
- van der Horst C, Saag MS, Cloud GA, Hamill RJ, Graybill JR, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 1997;337:15–21. - PubMed
-
- Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, et al. Combination antifungal therapies for HIV-associated crytpococcal meningitis: A randomised trial. Lancet. 2004;363:1764–1767. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
